Similar articles

• [Pacemaker stimulation in dilated and hypertrophic myocardiopathies: should its use be stratified?].

  López Meneses M, Olvera Cruz S. López Meneses M, et al. Arch Cardiol Mex. 2002 Jan-Mar;72 Suppl 1:S117-21. Arch Cardiol Mex. 2002. PMID: 12001828 Spanish.
• Regression of dilated-hypokinetic hypertrophic cardiomyopathy by biventricular cardiac pacing.

  Ashrafian H, Mason MJ, Mitchell AG. Ashrafian H, et al. Europace. 2007 Jan;9(1):50-4. doi: 10.1093/europace/eul137. Europace. 2007. PMID: 17224423
• [New indications for cardiac pacing].

  Davy JM, Pons M, Beck L, Ferrière M. Davy JM, et al. Arch Mal Coeur Vaiss. 1995 Dec;88 Spec No 5:55-62. Arch Mal Coeur Vaiss. 1995. PMID: 8729301 Review. French.
• [Impact of electric cardiac stimulation on ventricular function and the natural history of patients with myocardiopathy].

  Tascón JC, Kabbani Z, Albarrán A, Carnero A, Rodríguez J. Tascón JC, et al. Rev Esp Cardiol. 1996 Aug;49(8):598-608. Rev Esp Cardiol. 1996. PMID: 8756204 Review. Spanish.
• The newer unconventional indications of permanent pacemakers.

  Panja M, Mazumdar A, Ghosh S, Mazumdar B, Kar AK, Mondal P. Panja M, et al. J Assoc Physicians India. 2000 Dec;48(12):1193-6. J Assoc Physicians India. 2000. PMID: 11280227 Review.